
    
      Inclusion Criteria:

        -  Subject has a diagnosis of ITP according to the American Society of Hematology
           guidelines (George et al., 1996).

        -  Subject is equal to or greater than 18 years of age.

        -  Before any study-specific procedure, the appropriate written informed consent must be
           obtained.

        -  Subject receiving romiplostim in the compassionate program

        -  Available follow-up of one-year

      Exclusion Criteria:

      â€¢Secondary ITP e.g: thrombopenia related to hepatitis C, HIV, Chronic Lymphocytic Leukemia...

      The goal of this study is to review retrospectively the charts of the 100 first patients
      including in this program in France during the period of January 2008 and July 2008.
    
  